Dr. Lal PathLabs reported a robust financial performance for the first quarter of FY26, with net profit rising 24% year-on-year to ₹132 crore. The company’s revenue grew by 11.3%, reaching ₹670 crore, driven by higher diagnostic volumes and operational efficiency. In addition to its strong earnings, the board of directors declared an interim dividend of […]
